Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Insulin Isophane

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00941148Phase 4Completed

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

Showing all 1 trials

Research Network

Common Treatments

  • Insulin Isophane1
  • Insulin Glargin1
  • Metformin1
  • Insulin Detemir1

Active Sponsors

  • ikfe-CRO GmbH1
  • IKFE Institute for Clinical Research and Development1

Related Conditions

  • Type 2 Diabetic Patients1
  • Oad Treatment1

Activity Timeline